Debrisoquine hydroxylase gene polymorphism (CYP2D6*4) in dementia with Lewy bodies

被引：6

作者：

Huckvale, C

Richardson, AMT

Mann, DMA ^{[1
]}

Pickering-Brown, SM

机构：

[1] Univ Manchester, Hope Hosp, Clin Neurosci Res Grp, Salford M6 8HD, Lancs, England

[2] Univ Manchester, Hope Hosp, Greater Manchester Neurosci Ctr, Dept Neurol, Salford M6 8HD, Lancs, England

[3] Univ London, Inst Psychiat, Dept Old Age Psychiat, London WC1E 7HU, England

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2003年 / 74卷 / 01期

关键词：

D O I：

10.1136/jnnp.74.1.135

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：135 / 136

页数：2

共 10 条

[1] CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease [J].

Atkinson, A ;

Singleton, AB ;

Steward, A ;

Ince, PG ;

Perry, RH ;

McKeith, IG ;

Fairbairn, AF ;

Edwardson, JA ;

Daly, AK ;

Morris, CM .

PHARMACOGENETICS, 1999, 9 (01) :31-35

[2] No evidence of an association between CYP2D6 polymorphisms among Japanese and dementia with Lewy bodies [J].

Furuno, T ;

Kawanishi, C ;

Iseki, E ;

Onishi, H ;

Sugiyama, N ;

Suzuki, K ;

Kosaka, K .

PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 55 (02) :89-92

[3] Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop [J].

McKeith, IG ;

Galasko, D ;

Kosaka, K ;

Perry, EK ;

Dickson, DW ;

Hansen, LA ;

Salmon, DP ;

Lowe, J ;

MIrra, SS ;

Byrne, EJ ;

Lennox, G ;

Quinn, NP ;

Edwardson, JA ;

Ince, PG ;

Bergeron, C ;

Burns, A ;

Miller, BL ;

Lovestone, S ;

Collerton, D ;

Jansen, ENH ;

Ballard, C ;

deVos, RAI ;

Wilcock, GK ;

Jellinger, KA ;

Perry, RH .

NEUROLOGY, 1996, 47 (05) :1113-1124

[4]

Perry R H, 1989, Lancet, V1, P166

[5] APOLIPOPROTEIN E4 AND ALZHEIMERS-DISEASE PATHOLOGY IN LEWY BODY DISEASE AND IN OTHER BETA-AMYLOID-FORMING DISEASES [J].

PICKERINGBROWN, SM ;

MANN, DMA ;

BOURKE, JP ;

ROBERTS, DA ;

BALDERSON, D ;

BURNS, A ;

BYRNE, J ;

OWEN, F .

LANCET, 1994, 343 (8906) :1155-1155

[6] Dementia with Lewy bodies and Alzheimer's disease [J].

Rosenberg, CK ;

Cummings, TJ ;

Saunders, AM ;

Widico, C ;

McIntyre, LM ;

Hulette, CM .

ACTA NEUROPATHOLOGICA, 2001, 102 (06) :621-626

[7] THE CYP2D6B MUTANT ALLELE IS OVERREPRESENTED IN THE LEWY BODY VARIANT OF ALZHEIMERS-DISEASE [J].

SAITOH, T ;

XIA, Y ;

CHEN, X ;

MASLIAH, E ;

GALASKO, D ;

SHULTS, C ;

THAL, LJ ;

HANSEN, LA ;

KATZMAN, R .

ANNALS OF NEUROLOGY, 1995, 37 (01) :110-112

[8] DEBRISOQUINE HYDROXYLASE GENE POLYMORPHISM AND SUSCEPTIBILITY TO PARKINSONS-DISEASE [J].

SMITH, CAD ;

GOUGH, AC ;

LEIGH, PN ;

SUMMERS, BA ;

HARDING, AE ;

MARANGANORE, DM ;

STURMAN, SG ;

SCHAPIRA, AHV ;

WILLIAMS, AC ;

SPURR, NK ;

WOLF, CR .

LANCET, 1992, 339 (8806) :1375-1377

[9] Association of CYP2D microsatellite polymorphism with lewy body variant of Alzheimer's disease [J].

Tanaka, S ;

Chen, X ;

Xia, Y ;

Kang, DE ;

Matoh, N ;

Sundsmo, M ;

Thomas, RG ;

Katzman, R ;

Thal, LJ ;

Trojanowski, JQ ;

Saitoh, T ;

Ueda, K ;

Masliah, E .

NEUROLOGY, 1998, 50 (06) :1556-1562

[10] APOLIPOPROTEIN-E GENOTYPING BY ONE-STAGE PCR [J].

WENHAM, PR ;

PRICE, WH ;

BLUNDELL, G .

LANCET, 1991, 337 (8750) :1158-1159

← 1 →